Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Vyne Therapeutics

Explore full profile

Late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus

Menlo Park, United StatesFounded 2011Biotech & Life Sciences
Revenue $570K Latest reported FY
Total funding $100–500M Disclosed equity funding

About Vyne Therapeutics

VYNE Therapeutics is an entrepreneurial biopharmaceutical company focused on developing innovative and differentiated therapies to address some of the most difficult therapeutic challenges. The company leverages its existing development capabilities and a strong network of discovery and preclinical science partners to advance new medicines through the clinical pipeline. VYNE Therapeutics operates in the biopharmaceutical market, primarily serving patients with unmet medical needs. The business model revolves around the development and commercialization of proprietary therapies, generating revenue through product sales and potential partnerships or licensing agreements. The company's approach is rooted in questioning traditional assumptions and finding better solutions, driven by a culture of collaborative teamwork and independent thinking.

Source: Dealroom company data

At a glance

Founded
2011
Headquarters
Menlo Park, United States
Listing
IPO 2018
Sector
Biotech & Life Sciences

Latest news

Press, funding announcements and product moves mentioning Vyne Therapeutics.

See all news

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

Series B and later5 investors entered at this stage

  • Aisling Capital
  • Bay City Capital
  • Rock Springs Capital
  • Novo Holdings
  • venBio Partners

Talent

Book a demo to see the people
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Vyne Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vyne Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles